A fasting-mimicking diet consisting of a 4-day plant-based low amino-acid substitution diet is safe and effective as an adjunct to neoadjuvant chemotherapy in women with HER2-negative stage II/III breast cancer (NCT02126449) (de Groot et al., 2020). This evidence concerns the gene ERBB2 and breast cancer.